Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Correlation between GPR174 protein expression and clinicopathological features of 98 patients with esophageal squamous cell carcinoma

From: The LysoPS/GPR174 axis drives metastatic progression in esophageal squamous cell carcinoma through cAMP-PKA-CREB signaling activation

Clinicopathological variables

n

GPR174 expression

P valuea

Low

High

Age

   

0.102

 < 60

30

8

22

 

 ≥ 60

68

30

38

 

Gender

   

0.638

 Female

15

5

10

 

 Male

83

33

50

 

Tumor Size

   

0.290

 < 5 cm

58

25

33

 

 ≥ 5 cm

40

13

27

 

Differentiation

   

0.478

 Well and moderate

71

26

45

 

 Poorly and not

27

12

15

 

TNM stagesb

   

< 0.0001*

 I–II

38

24

14

 

 III–IV

60

14

46

 

Tumor invasion

   

0.071

 T1–T2

13

8

5

 

 T3–T4

85

30

55

 

Lymphatic invasion

   

< 0.001*

 N0

39

23

16

 

 N1–N3

59

15

44

 
  1. aAll P values were determined by chi-square test; bTNM staging was AJCC 7th edition staging
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us